Publications

You are here:
  1. Home
  2. Category "Publications"
Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors

Open access: Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors | Acta Neuropathologica Communications | Full Text Rebecca R. J. Collins, Rebecca R. Florke Gee, Sima Tozandehjani, Tara Bayat, Maria Camila Hoyos Sanchez, Juan Sebastian Solano Gutierrez, Barbara Breznik, Anna K. Lee, Samuel T. Peters, Jon P. Connelly,…

Read article
The Slovenian translational platform GlioBank for brain tumor research: Identification of molecular signatures of glioblastoma progression

Open access: https://doi.org/10.1016/j.isci.2024.110604 Metka Novak, Bernarda Majc, Marta Malavolta, Andrej Porčnik, Jernej Mlakar, Matjaž Hren, Anamarija Habič, Mateja Mlinar, Ivana Jovčevska, Neja Šamec, Alja Zottel, Marija Skoblar Vidmar, Tina Vipotnik Vesnaver, Andrej Zupan, Alenka Matjašič, Saša Trkov Bobnar, Dejan Georgiev, Aleksander Sadikov, Roman Bošnjak, Borut Prestor, Radovan Komel, Tamara Lah Turnšek, Barbara Breznik Glioblastoma is…

Read article
CutCancer at 52nd European environmental mutagenesis and genomics society (EEMGS) and 15th International Comet Assay Workshop congress in Rovinj, Croatia, September 2024.

During 2024 EEMGS and ICAW congress in Rovinj, Croatia, researchers from National Institute of Biology presented CutCancer project in the form of poster. ŠTERN, Alja, BREZNIK, Barbara, NOVAK, Metka, DOAK Shareen Heather, VAN MALDEGEM, Febe, NILSSON Mats, ŽEGURA, Bojana, EEMGS Annual Meeting and ICAW meeting, 23.-27 Sep. 2024, Rovinj. CutCancer : a twinning approach to…

Read article
52nd European environmental mutagenesis and genomics society (EEMGS) and 15th International Comet Assay Workshop congress in Rovinj, Croatia, September 2024.

During 2024 EEMGS and ICAW congress in Rovinj, Croatia, researchers from National Institute of Biology presented their CutCancer related work as a posters. KOLOŠA, Katja, ŠTERN, Alja, ŽABKAR, Sonja, ROZMAN, Iza, ŽEGURA, Bojana, et al., EEMGS Annual Meeting and ICAW meeting, 23.-27 Sep. 2024, Rovinj. Genotoxicity assessment of Vanadium-doped iron-oxide nanozymes in HepG2 cells. Arhiv…

Read article
Exploring the safety of cannabidiol (CBD): A comprehensive in vitro evaluation of the genotoxic and mutagenic potential of a CBD isolate and extract from Cannabis sativa L

https://doi.org/10.1016/j.biopha.2024.116969 Alja Štern, Matjaž Novak, Katja Kološa, Jurij Trontelj, Sonja Žabkar, Tjaša Šentjurc, Metka Filipič, Bojana ŽeguraCannabidiol (CBD), a naturally occurring cyclic terpenoid found in Cannabis sativa L., is renowned for its diverse pharmacological benefits. Marketed as a remedy for various health issues, CBD products are utilized by patients as a supplementary therapy or post-treatment failure, as well as by…

Read article
Patient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastoma

Open access: https://doi.org/10.1016/j.isci.2024.110604 Bernarda Majc, Anamarija Habič, Marta Malavolta, Miloš Vittori, Andrej Porčnik, Roman Bošnjak, Jernej Mlakar, Alenka Matjašič, Andrej Zupan, Marija Skoblar Vidmar, Tamara Lah Turnšek, Aleksander Sadikov, Barbara Breznik, Metka Novak Glioblastoma (GB) is the most common primary malignant brain tumor, characterized by resistance to therapy. Despite aggressive treatment options, GB remains an…

Read article
EACR congress in Rotterdam June 2024

Barbara Breznik presented research work at the EACR congress in Rotterdam (10-13 June) in a form of poster presentation. She presented work, entitled »Utilizing translational platform GlioBank to identify novel molecular signatures of glioblastoma progression«.  Glioblastoma (GBM) is one of the most lethal solid tumors in humans. Currently, GBM is considered incurable and there is…

Read article